https://www.cancernetwork.com/view/tumor-lysis-syndrome-and-the-feasibility-of-an-all-oral-regimen2026-06-30https://cdn.sanity.io/images/0vv8moc6/cancernetwork/ac4c20736a7bb18ff95abd426aa616e7506504ea-932x522.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399826699112 https://www.cancernetwork.com/view/rationale-for-pairing-sonrotoclax-with-zanubrutinib-in-relapsed-or-refractory-cll2026-06-30https://cdn.sanity.io/images/0vv8moc6/cancernetwork/ac4c20736a7bb18ff95abd426aa616e7506504ea-932x522.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399827848112 https://www.cancernetwork.com/view/the-unmet-needs-driving-new-mechanisms-in-b-cell-malignancies2026-06-30https://cdn.sanity.io/images/0vv8moc6/cancernetwork/ac4c20736a7bb18ff95abd426aa616e7506504ea-932x522.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399827847112 https://www.cancernetwork.com/view/looking-to-the-future-and-where-these-agents-may-fit-in-sequencing2026-06-30https://cdn.sanity.io/images/0vv8moc6/cancernetwork/ac4c20736a7bb18ff95abd426aa616e7506504ea-932x522.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399825940112 https://www.cancernetwork.com/view/efficacy-and-durability-of-catadegbrutinib-in-relapsed-or-refractory-waldenstr-m-macroglobulinemia2026-06-30https://cdn.sanity.io/images/0vv8moc6/cancernetwork/ac4c20736a7bb18ff95abd426aa616e7506504ea-932x522.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399825747112 https://www.cancernetwork.com/view/how-btk-degradation-differs-from-inhibition2026-06-30https://cdn.sanity.io/images/0vv8moc6/cancernetwork/ac4c20736a7bb18ff95abd426aa616e7506504ea-932x522.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399825255112 https://www.cancernetwork.com/view/the-unmet-need-driving-new-mechanisms-in-b-cell-malignancies2026-06-30https://cdn.sanity.io/images/0vv8moc6/cancernetwork/ac4c20736a7bb18ff95abd426aa616e7506504ea-932x522.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399826235112 https://www.cancernetwork.com/view/biomarker-interpretation-and-high-risk-disease-definitions-in-cll2026-06-30https://cdn.sanity.io/images/0vv8moc6/cancernetwork/28de994e5bd7f6e3b1af99ee70a877443ea899a8-928x520.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399476311112 https://www.cancernetwork.com/view/relapsed-refractory-multiple-myeloma-cartitude-4-and-the-evolving-role-of-bcma-car-t-cell-therapy2026-06-30https://cdn.sanity.io/images/0vv8moc6/cancernetwork/e385b3597c35077e501588824deb6d77b414a42b-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399737430112 https://www.cancernetwork.com/view/cns-disease-management-and-screening-strategies-in-her2-positive-metastatic-breast-cancer2026-06-30https://cdn.sanity.io/images/0vv8moc6/cancernetwork/96cca548b474372824afc8f87879ac63c2475b1d-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6398680402112 https://www.cancernetwork.com/view/her2-positive-metastatic-breast-cancer-patient-selection-and-treatment-duration-considerations2026-06-30https://cdn.sanity.io/images/0vv8moc6/cancernetwork/96cca548b474372824afc8f87879ac63c2475b1d-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6398679054112 https://www.cancernetwork.com/view/relapsed-refractory-multiple-myeloma-setting-the-stage-for-bcma-directed-treatment-strategies2026-06-30https://cdn.sanity.io/images/0vv8moc6/cancernetwork/e385b3597c35077e501588824deb6d77b414a42b-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399738478112 https://www.cancernetwork.com/view/overview-of-first-line-cll-treatment-strategies2026-06-30https://cdn.sanity.io/images/0vv8moc6/cancernetwork/28de994e5bd7f6e3b1af99ee70a877443ea899a8-928x520.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399476596112 https://www.cancernetwork.com/view/mariposa-prophylaxis-biomarkers-and-cns-debate2026-06-29https://cdn.sanity.io/images/0vv8moc6/cancernetwork/1fe7502990a39da4a57f9caf06786cff7c2c8bb2-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399725469112 https://www.cancernetwork.com/view/mariposa-trial-egfr-mutant-lung-cancer-frontline-strategies2026-06-29https://cdn.sanity.io/images/0vv8moc6/cancernetwork/1fe7502990a39da4a57f9caf06786cff7c2c8bb2-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399727765112 https://www.cancernetwork.com/view/tropion-breast02-and-quality-of-life-considerations2026-06-29https://cdn.sanity.io/images/0vv8moc6/cancernetwork/2f1b5187086d6d06a74cb3295ac6a2e72b4c1a8a-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399111513112 https://www.cancernetwork.com/view/clinical-scenario-1-high-risk-adjuvant-setting-in-cscc-treatment2026-06-29https://cdn.sanity.io/images/0vv8moc6/cancernetwork/67b35a74c0a9ab7f22a9299700321e0c7799e0bc-1920x1080.jpghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6398070486112 https://www.cancernetwork.com/view/maia-efficacy-and-mrd-outcomes-in-newly-diagnosed-multiple-myeloma2026-06-29https://cdn.sanity.io/images/0vv8moc6/cancernetwork/a00c5b2cb4a26299bed0f8de2553e53aeb80a099-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6398485094112 https://www.cancernetwork.com/view/defining-anti-cd38-refractory-disease-in-relapsed-refractory-multiple-myeloma2026-06-29https://cdn.sanity.io/images/0vv8moc6/cancernetwork/ec80187078888b92e2a7be451eebdb324ea9cabc-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399473010112 https://www.cancernetwork.com/view/systemic-treatment-options-for-cscc-and-mechanism-of-action2026-06-29https://cdn.sanity.io/images/0vv8moc6/cancernetwork/29beccff572cb2b27e5107197062d0fbe40abab7-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399392178112 https://www.cancernetwork.com/view/cscc-disease-progression-and-comorbidity-considerations2026-06-29https://cdn.sanity.io/images/0vv8moc6/cancernetwork/29beccff572cb2b27e5107197062d0fbe40abab7-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399393552112 https://www.cancernetwork.com/view/evolving-treatment-strategies-in-relapsed-refractory-multiple-myeloma-integrating-bispecific-antibodies-into-earlier-lines-of-care2026-06-29https://cdn.sanity.io/images/0vv8moc6/cancernetwork/ec80187078888b92e2a7be451eebdb324ea9cabc-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399475354112 https://www.cancernetwork.com/view/maia-long-term-outcomes-in-newly-diagnosed-multiple-myeloma2026-06-29https://cdn.sanity.io/images/0vv8moc6/cancernetwork/a00c5b2cb4a26299bed0f8de2553e53aeb80a099-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6398485887112 https://www.cancernetwork.com/view/real-world-data-and-neoadjuvant-use-in-cscc2026-06-29https://cdn.sanity.io/images/0vv8moc6/cancernetwork/67b35a74c0a9ab7f22a9299700321e0c7799e0bc-1920x1080.jpghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6398070781112 https://www.cancernetwork.com/view/ascent-07-and-triple-negative-breast-cancer-advances2026-06-29https://cdn.sanity.io/images/0vv8moc6/cancernetwork/2f1b5187086d6d06a74cb3295ac6a2e72b4c1a8a-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399111594112 https://www.cancernetwork.com/view/wrapping-a-warm-blanket-around-patients-in-a-state-of-the-art-center2026-06-27https://cdn.sanity.io/images/0vv8moc6/cancernetwork/f333345e2a59f1e0d913b76ff8dc06eeb38cdf2c-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399392224112 https://www.cancernetwork.com/view/overcoming-pd-1-resistance-in-relapsed-refractory-hodgkin-lymphoma2026-06-26https://cdn.sanity.io/images/0vv8moc6/cancernetwork/d4c0d52adc4bbedeebb5241a0f23ffd2936c463f-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399382181112 https://www.cancernetwork.com/view/reviewing-the-himalaya-trial-of-tremelimumab-plus-durvalumab-in-unresectable-hcc2026-06-26https://cdn.sanity.io/images/0vv8moc6/cancernetwork/cabf8c772800a6812c20411dc26c291b2ee759d7-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399484647112 https://www.cancernetwork.com/view/opening-remarks-and-the-frontline-treatment-landscape-in-advanced-hcc2026-06-26https://cdn.sanity.io/images/0vv8moc6/cancernetwork/cabf8c772800a6812c20411dc26c291b2ee759d7-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399484850112 https://www.cancernetwork.com/view/dr-nicholas-hornstein-on-ctdna-colorectal-cancer-why-better-drugs-are-coming2026-06-26https://cdn.sanity.io/images/0vv8moc6/cancernetwork/54570084eb1ac0d6da8bb43351d44b9ae9a06647-1909x1044.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399292031112 https://www.cancernetwork.com/view/relapsed-refractory-multiple-myeloma-redefining-treatment-at-first-relapse2026-06-26https://cdn.sanity.io/images/0vv8moc6/cancernetwork/15c7813dd2953358e65647da81919a6870316f0d-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399374904112 https://www.cancernetwork.com/view/relapsed-refractory-multiple-myeloma-evolving-treatment-strategies-after-frontline-quadruplets2026-06-26https://cdn.sanity.io/images/0vv8moc6/cancernetwork/15c7813dd2953358e65647da81919a6870316f0d-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399375087112 https://www.cancernetwork.com/view/where-do-bispecific-antibodies-stand-in-the-follicular-lymphoma-landscape-2026-06-25https://cdn.sanity.io/images/0vv8moc6/cancernetwork/5b1d11c50320f3e27e02251bc45506a00322fd6a-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399178279112 https://www.cancernetwork.com/view/glp-1s-in-breast-cancer-overall-survival-recurrence-risk-and-safety2026-06-25https://cdn.sanity.io/images/0vv8moc6/cancernetwork/769bb1933aef194e501c858ba2b2439933912436-1920x1080.jpghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6398777521112 https://www.cancernetwork.com/view/efficacy-of-glp-1-receptor-agonists-in-breast-cancer-populations2026-06-24https://cdn.sanity.io/images/0vv8moc6/cancernetwork/12e81383fccc180c85b4b50cf849380d9919ef9a-1920x1080.jpghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6398779190112 https://www.cancernetwork.com/view/frontline-treatment-selection-and-shared-decision-making2026-06-24https://cdn.sanity.io/images/0vv8moc6/cancernetwork/bf18124ff0b2b4bf90e121d3c7946610edb70425-918x518.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6398158015112 https://www.cancernetwork.com/view/why-managing-post-diagnosis-weight-gain-is-critical-in-breast-cancer-care2026-06-23https://cdn.sanity.io/images/0vv8moc6/cancernetwork/a7006832406a94804381faaee2ec55051ded68a6-1920x1080.jpghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6398777915112 https://www.cancernetwork.com/view/asco-2026-data-refinements-and-deep-response-analysis-in-her2-positive-metastatic-breast-cancer2026-06-23https://cdn.sanity.io/images/0vv8moc6/cancernetwork/96cca548b474372824afc8f87879ac63c2475b1d-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6398680214112 https://www.cancernetwork.com/view/current-treatment-landscape-of-her2-positive-metastatic-breast-cancer-and-phase-3-trial-overview2026-06-23https://cdn.sanity.io/images/0vv8moc6/cancernetwork/96cca548b474372824afc8f87879ac63c2475b1d-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6398680600112 https://www.cancernetwork.com/view/tropion-breast01-and-comparative-adc-data2026-06-22https://cdn.sanity.io/images/0vv8moc6/cancernetwork/2f1b5187086d6d06a74cb3295ac6a2e72b4c1a8a-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399112665112 https://www.cancernetwork.com/view/introduction-and-treatment-landscape-overview2026-06-22https://cdn.sanity.io/images/0vv8moc6/cancernetwork/2f1b5187086d6d06a74cb3295ac6a2e72b4c1a8a-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6399112096112 https://www.cancernetwork.com/view/exploring-the-future-of-bladder-sparing-regimens-in-the-mibc-landscape2026-06-22https://cdn.sanity.io/images/0vv8moc6/cancernetwork/6fafe2a541a355d98d1f0fe67fa0c8ae7a67f066-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6398879264112 https://www.cancernetwork.com/view/the-moonlight-shift-dr-joshua-richter-on-myeloma-myths-and-the-c-word2026-06-22https://cdn.sanity.io/images/0vv8moc6/cancernetwork/54570084eb1ac0d6da8bb43351d44b9ae9a06647-1909x1044.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6398157520112 https://www.cancernetwork.com/view/checkpoint-inhibitor-evidence-empower-and-c-post-trials2026-06-22https://cdn.sanity.io/images/0vv8moc6/cancernetwork/67b35a74c0a9ab7f22a9299700321e0c7799e0bc-1920x1080.jpghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6398071279112 https://www.cancernetwork.com/view/daratumumab-based-frontline-therapy-in-newly-diagnosed-multiple-myeloma2026-06-22https://cdn.sanity.io/images/0vv8moc6/cancernetwork/a00c5b2cb4a26299bed0f8de2553e53aeb80a099-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6398485007112 https://www.cancernetwork.com/view/when-to-consider-systemic-therapy-for-cscc2026-06-22https://cdn.sanity.io/images/0vv8moc6/cancernetwork/67b35a74c0a9ab7f22a9299700321e0c7799e0bc-1920x1080.jpghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6398070290112 https://www.cancernetwork.com/view/evolving-frontline-management-in-newly-diagnosed-multiple-myeloma2026-06-22https://cdn.sanity.io/images/0vv8moc6/cancernetwork/a00c5b2cb4a26299bed0f8de2553e53aeb80a099-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6398484502112 https://www.cancernetwork.com/view/how-do-you-choose-the-right-frontline-therapy-in-cll-care-2026-06-21https://cdn.sanity.io/images/0vv8moc6/cancernetwork/56df7b931d2057192e9c65d23a4f68ba67c17a72-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6398874961112 https://www.cancernetwork.com/view/historical-evolution-and-current-treatment-landscape2026-06-17https://cdn.sanity.io/images/0vv8moc6/cancernetwork/bf18124ff0b2b4bf90e121d3c7946610edb70425-918x518.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6398157233112 https://www.cancernetwork.com/view/multidisciplinary-referral-for-patients-with-cscc-and-care-transitions2026-06-15https://cdn.sanity.io/images/0vv8moc6/cancernetwork/67b35a74c0a9ab7f22a9299700321e0c7799e0bc-1920x1080.jpghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6398068913112 https://www.cancernetwork.com/view/introduction-and-current-landscape-of-cutaneous-squamous-cell-carcinoma2026-06-15https://cdn.sanity.io/images/0vv8moc6/cancernetwork/67b35a74c0a9ab7f22a9299700321e0c7799e0bc-1920x1080.jpghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6398070104112 https://www.cancernetwork.com/view/pirtobrutinib-regimen-may-offer-prolonged-remissions-in-pretreated-cll2026-06-14https://cdn.sanity.io/images/0vv8moc6/cancernetwork/8986244fc516a8c0b9b38ad474fc1d22761c5c2d-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6398390693112 https://www.cancernetwork.com/view/asciminib-may-offer-longer-better-life-in-frontline-cml-care2026-06-10https://cdn.sanity.io/images/0vv8moc6/cancernetwork/a5d2659f7a0556c419d34f33aa9cbfdbbcb8d2db-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6398006085112 https://www.cancernetwork.com/view/rethinking-academic-support-sustainability-for-clinical-cancer-research2026-06-10https://cdn.sanity.io/images/0vv8moc6/cancernetwork/2235b5e5a76d7f3ed622935f95b9e2f1519311e7-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6398003962112 https://www.cancernetwork.com/view/when-to-replace-aromatase-inhibitors-with-serds-in-er-her2-advanced-mbc2026-06-08https://cdn.sanity.io/images/0vv8moc6/cancernetwork/5b11b2adb1f7e461f161efd65629b0c864cdb96c-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6397653295112 https://www.cancernetwork.com/view/is-the-juice-worth-the-squeeze-optimizing-adjuvant-combinations-in-rcc2026-06-08https://cdn.sanity.io/images/0vv8moc6/cancernetwork/533be15e5beed90cf28d15ea2eafdbf7fe985ef3-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6397658922112 https://www.cancernetwork.com/view/menin-inhibition-shows-utility-in-heterogenous-aml-population2026-06-06https://cdn.sanity.io/images/0vv8moc6/cancernetwork/3fe17ad708c2b8724b6333bebdc9c4ff738b3213-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6397643048112 https://www.cancernetwork.com/view/senomac-reveals-omitting-alnd-yields-non-inferior-survival-in-breast-cancer2026-06-05https://cdn.sanity.io/images/0vv8moc6/cancernetwork/04971b426a1abdd458db42ec182a758f8553905a-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6397549779112 https://www.cancernetwork.com/view/around-the-practice-setting-the-stage-in-advanced-cutaneous-squamous-cell-carcinoma2026-06-04https://cdn.sanity.io/images/0vv8moc6/cancernetwork/cd691dfe4c58321fabebf74c953710c2cc94d301-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6397562776112 https://www.cancernetwork.com/view/what-is-the-utility-of-tumor-growth-rate-in-glioma-treatment-2026-06-04https://cdn.sanity.io/images/0vv8moc6/cancernetwork/2d36e408e710038207856750533d9d13e657abc1-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6397444282112 https://www.cancernetwork.com/view/mitigating-skin-rash-in-rmc-de-escalation-of-panitumumab-based-triplets2026-06-04https://cdn.sanity.io/images/0vv8moc6/cancernetwork/69b1ced0db45a85944bee6346319176e93014930-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6397447160112 https://www.cancernetwork.com/view/decoding-rampart-durvalumab-monotherapy-vs-combination-therapy-in-rcc2026-06-03https://cdn.sanity.io/images/0vv8moc6/cancernetwork/d124c2b4ce3cb82403946da69fad16ce614f7908-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6397455228112 https://www.cancernetwork.com/view/hitting-hard-and-early-using-radioligand-therapy-earlier-in-mhspc2026-06-03https://cdn.sanity.io/images/0vv8moc6/cancernetwork/cd4ee81b41c4d0db91c8f94d2ecfafd34e9e5dcc-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6397235430112 https://www.cancernetwork.com/view/asco-2026-dynamic-therapy-interventions-with-psma-in-metastatic-hspc2026-06-02https://cdn.sanity.io/images/0vv8moc6/cancernetwork/7c4cf0b0b67c58f9a2e3f08fa82df815dd8729a6-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6397062109112 https://www.cancernetwork.com/view/summary-putting-it-all-together-for-1l-egfrm-nsclc2026-06-02https://cdn.sanity.io/images/0vv8moc6/cancernetwork/f8a498b641f2bef281beb0574a4ef2936172662a-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6395256229112 https://www.cancernetwork.com/view/fedratinib-is-uniquely-positioned-in-mds-mpn-treatment2026-06-02https://cdn.sanity.io/images/0vv8moc6/cancernetwork/526d2560ccc4aa39e95c7ac7f9a2fd2a108046ca-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6397213115112 https://www.cancernetwork.com/view/ai-tool-shows-prostate-cancer-genetic-testing-feasibility-in-community-care2026-06-01https://cdn.sanity.io/images/0vv8moc6/cancernetwork/0bdb0896c91c024e3bd3d9afc2055e27b580f29d-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6396991267112 https://www.cancernetwork.com/view/sc-amivantamab-may-provide-more-convenience-in-chrysalis-2-regimen2026-05-31https://cdn.sanity.io/images/0vv8moc6/cancernetwork/28141f2cb74c851cbcf499f5417c0c58aa7caf88-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6397062750112 https://www.cancernetwork.com/view/sequencing-adcs-in-breast-cancer-key-clinical-decision-markers2026-05-30https://cdn.sanity.io/images/0vv8moc6/cancernetwork/6e291635a0a5e9e27dedec90ee08f487a45b1abc-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6397058063112 https://www.cancernetwork.com/view/can-structured-exercise-reprogram-the-tumor-microenvironment-in-oncology-2026-05-29https://cdn.sanity.io/images/0vv8moc6/cancernetwork/8869585de9f856db9386d839df6221711a647fa3-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6396779653112 https://www.cancernetwork.com/view/the-moonlight-shift-maurie-markman-oncology-biggest-problems2026-05-28https://cdn.sanity.io/images/0vv8moc6/cancernetwork/54570084eb1ac0d6da8bb43351d44b9ae9a06647-1909x1044.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6396814178112 https://www.cancernetwork.com/view/exercise-regimens-could-disrupt-accelerated-cellular-aging-in-cancer2026-05-26https://cdn.sanity.io/images/0vv8moc6/cancernetwork/bd2e01e2df13ed9bb9ad2cada8be7c77d939bb51-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6396663268112 https://www.cancernetwork.com/view/optimizing-the-treatment-experience-cocoon-counseling-and-anticoagulation2026-05-26https://cdn.sanity.io/images/0vv8moc6/cancernetwork/f8a498b641f2bef281beb0574a4ef2936172662a-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6395255540112 https://www.cancernetwork.com/view/navigating-car-t-cell-therapy-use-as-a-team-sport-in-multiple-myeloma2026-05-26https://cdn.sanity.io/images/0vv8moc6/cancernetwork/4b878ef0f9d9e8db65bc666b0cd7f891441c3656-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6396375880112 https://www.cancernetwork.com/view/safety-tolerability-and-the-ae-profile-of-sc-q4w-in-cohort-52026-05-26https://cdn.sanity.io/images/0vv8moc6/cancernetwork/f8a498b641f2bef281beb0574a4ef2936172662a-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6395258000112 https://www.cancernetwork.com/view/discussing-chemo-trends-and-end-point-selection-in-older-patients-with-tnbc2026-05-21https://cdn.sanity.io/images/0vv8moc6/cancernetwork/aa8ed21bfe68c6cf7058ba46f7b784a48398fa5d-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6396166028112 https://www.cancernetwork.com/view/alpha-dart-elicits-100-local-disease-control-in-pancreatic-cancer2026-05-21https://cdn.sanity.io/images/0vv8moc6/cancernetwork/f7c2bdd00668eff363e925628d588e2d1ae296ab-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6396143246112 https://www.cancernetwork.com/view/alpha-dart-overcomes-anatomical-constraints-in-inoperable-pancreatic-cancer2026-05-20https://cdn.sanity.io/images/0vv8moc6/cancernetwork/a296a638d20d616f7994ccb83d5773a94c4f73c7-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6396144793112 https://www.cancernetwork.com/view/the-potential-benefits-of-once-daily-extended-release-ruxolitinib-tablets2026-05-20https://cdn.sanity.io/images/0vv8moc6/cancernetwork/2cc2406097a38a96f69b2311e45c6f824916aec0-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6395706695112 https://www.cancernetwork.com/view/discussing-multidisciplinary-coordination-for-mitomycin-gel-delivery2026-05-19https://cdn.sanity.io/images/0vv8moc6/cancernetwork/755a8a7ed887c3c602d128c2459cedcde8f6961b-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6396058353112 https://www.cancernetwork.com/view/sc-q4w-in-practice-workflow-dose-modifications-and-patient-conversations2026-05-19https://cdn.sanity.io/images/0vv8moc6/cancernetwork/f8a498b641f2bef281beb0574a4ef2936172662a-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6395256322112 https://www.cancernetwork.com/view/from-paloma-3-to-paloma-2-cohort-5-sc-q4w-dosing-evidence2026-05-19https://cdn.sanity.io/images/0vv8moc6/cancernetwork/f8a498b641f2bef281beb0574a4ef2936172662a-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6395255657112 https://www.cancernetwork.com/view/reflections-on-clinical-impact-and-future-data-needs2026-05-18https://cdn.sanity.io/images/0vv8moc6/cancernetwork/b7614e52fff7bdd6f4493c629c62e21f57b92a0c-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6392514366112 https://www.cancernetwork.com/view/summary-and-conclusions-of-litespark-0112026-05-18https://cdn.sanity.io/images/0vv8moc6/cancernetwork/b7614e52fff7bdd6f4493c629c62e21f57b92a0c-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6392515451112 https://www.cancernetwork.com/view/overcoming-knowledge-barriers-to-accessing-oncology-yoga-programs2026-05-16https://cdn.sanity.io/images/0vv8moc6/cancernetwork/ced5337a0c6c7862c7b9ffdb7ba88d599b27b050-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6395738832112 https://www.cancernetwork.com/view/identifying-psychoneurological-symptom-clusters-in-heme-malignancies2026-05-16https://cdn.sanity.io/images/0vv8moc6/cancernetwork/aa6313df8474b284c4b57041eb0a2b2bc920f26e-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6395731669112 https://www.cancernetwork.com/view/moving-beyond-r-chop-the-future-of-upfront-precision-oncology-in-lymphoma2026-05-15https://cdn.sanity.io/images/0vv8moc6/cancernetwork/3eccd236a75dc994c5723a90f5b792eb480b5b8e-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6395439352112 https://www.cancernetwork.com/view/moving-bispecifics-and-prophylaxis-to-outpatient-multiple-myeloma-care2026-05-15https://cdn.sanity.io/images/0vv8moc6/cancernetwork/f70d9e26633af62815b24f294d7e2926896e0e76-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6395433380112 https://www.cancernetwork.com/view/how-does-the-removal-of-heparin-impact-safety-in-oncology-care-2026-05-14https://cdn.sanity.io/images/0vv8moc6/cancernetwork/18a5acc96b0dec9c8534bda5ffb0af5e8c148085-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6395595963112 https://www.cancernetwork.com/view/breaking-silos-the-vital-role-of-oncology-training-programs-in-lymphoma2026-05-14https://cdn.sanity.io/images/0vv8moc6/cancernetwork/34241cf2cf08374cf7e5dc7146a51fba702892d9-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6395349726112 https://www.cancernetwork.com/view/the-unmet-needs-in-oncology-that-zedoresertib-lunresertib-targets2026-05-13https://cdn.sanity.io/images/0vv8moc6/cancernetwork/fbeb40a2cc322ac22be62160ecd9adffcb58f3d1-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6394352874112 https://www.cancernetwork.com/view/key-takeaways-for-early-relapse-multiple-myeloma-management2026-05-13https://cdn.sanity.io/images/0vv8moc6/cancernetwork/1037680179dd22031bb6c3ea404d1118f74f5c6e-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6392514624112 https://www.cancernetwork.com/view/how-til-therapy-provides-durable-responses-in-refractory-melanoma2026-05-13https://cdn.sanity.io/images/0vv8moc6/cancernetwork/7b0c87939e642d0cb9ee44c7a4d4b3e150e8c4cc-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6394588146112 https://www.cancernetwork.com/view/managing-comorbid-patients-in-early-relapse-multiple-myeloma2026-05-13https://cdn.sanity.io/images/0vv8moc6/cancernetwork/1037680179dd22031bb6c3ea404d1118f74f5c6e-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6392512990112 https://www.cancernetwork.com/view/how-is-zoldonrasib-different-from-other-therapies-in-kras-g12d-nsclc-2026-05-12https://cdn.sanity.io/images/0vv8moc6/cancernetwork/37233d51046b6e87c2a4ac4fc7761e58af34fe5c-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6395261176112 https://www.cancernetwork.com/view/mythic-trial-demonstrates-efficacy-in-platinum-resistant-ovarian-cancer2026-05-12https://cdn.sanity.io/images/0vv8moc6/cancernetwork/2e71763316b02031090c70144909ae74518ff269-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6394274418112 https://www.cancernetwork.com/view/selecting-among-preferred-1l-regimens-a-discussion2026-05-12https://cdn.sanity.io/images/0vv8moc6/cancernetwork/f8a498b641f2bef281beb0574a4ef2936172662a-1920x1080.pnghttps://players.brightcove.net/10203567001/dDZp7kuoR_default/index.html?videoId=6395256736112